Handbook of Helminthiasis for Public Health

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

ISBN: 9780849333286 | 0849333288
Cover: Hardcover
Copyright: 8/18/2006

Rent

(Recommended)

$168.80

Term

Due

Price

Semester

Dec 12

$177.68

Quarter

Aug 13

$168.80

Short Term

Jul 18

$159.91

*This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.
Buy New

Usually Ships in 3-5 Business Days

$227.47
eBook

Available Instantly

Online: 180 Days

Downloadable: 180 Days

$184.80

Written by internationally respected experts, Handbook of Human Helminthiasis provides information essential in the development of an integrated approach to the prevention, control and treatment of disease caused by endoparasitic helminths. The text is divided into sections dealing with the main groups of helminth infections and the diseases they induce. Each section addresses diagnostic techniques, epidemiology/distribution, pathogenesis, morbidity/pathology, treatment, prevention, and control. Emphasis is placed on methods for reducing morbidity, interrupting and reducing transmission, and techniques to prevent infection. This book is intended to be a practical manual for all involved in reducing the burden of disease and the economic costs of human helminthiasis.

PART I Human Health and Helminth Infection

(40)

Chapter 1 Helminthiasis — A Challenge to Health and Development

(22)

References

(3)

Helminth Species Recovered from Humans

(11)

References to Additions to the List

(2)

Chapter 2 One Day in the Life of Mumbua

(8)

2.1 Mumbua's Day

(4)

2.2 Comment

(1)

References

(3)

Chapter 3 Public Health Priorities: Decisions for Controlling Helminthiasis

(8)

3.1 Decisions Concerning the Control of Helminthiasis

(4)

3.1.1 Epidemiology

(1)

3.1.2 Morbidity and Mortality: Disease and Death

(1)

3.1.3 Community Response

(1)

3.1.4 Interventions

(1)

3.1.5 Donors and Partners

(1)

3.1.6 Sustainability

(1)

3.2 Economic Evaluations: Value for Money

(1)

3.3 Infrastructure and Integration

(1)

3.4 Summary

(2)

References

(1)

PART II Helminthology

(232)

Chapter 4 Common Themes and Concepts in Helminthiasis

(16)

4.1 History and Discovery

(1)

4.2 Nomenclature

(1)

4.3 Zoonotic Infections

(1)

4.4 Disease and Morbidity

(1)

4.5 Identification and Diagnosis

(3)

4.6 Immunity

(1)

4.7 Epidemiology and Population Biology

(3)

4.7.1 Surveys and Sampling

(1)

4.7.2 Prevalence and Intensity

(1)

4.7.3 Reproductive Rate

(2)

4.8 Deworming and Control Strategies

(2)

4.9 Prevention, Elimination, and Eradication

(1)

References

(5)

Chapter 5 Cestodiasis

(24)

5.1 Life Histories and Host Range

(7)

5.1.1 Development of Echinococcus and Cyst Formation

(5)

5.1.2 Development of Taenia and Cysticercus Formation

(1)

5.1.3 Host Range

(1)

5.1.4 Hymenolepis nana

(1)

5.2 Transmission to Humans

(1)

5.3 Diagnosis in Humans

(2)

5.3.1 Echinococcus and Taenia

(2)

5.3.1.1 Parasitological Diagnosis

(1)

5.3.1.2 Clinical Diagnosis

(1)

5.3.1.3 Immunodiagnosis and Molecular Diagnosis

(1)

5.3.2 Hymenolepis nana

(1)

5.4 Epidemiology

(3)

5.4.1 Echinococcus granulosus and E. multilocularis

(2)

5.4.2 Taenia caginata, Taenia asiatica, and Taenia solium

(1)

5.4.3 Hymenolepis nano

(1)

5.5 Morbidity and Pathology

(4)

5.5.1 Echinococcosis (CE and AE)

(1)

5.5.2 Taeniasis saginata and Taeniasis asiatica

(1)

5.5.3 Taeniasis solium (NCC)

(1)

5.5.4 Hymenolepiasis Due to Hymenolepis nana

(1)

5.5.5 Burden of Cestodiasis

(1)

5.6 Immunity

(1)

5.7 Anthelminthic Treatment

(1)

5.8 Prevention and Control

(2)

References

(4)

Chapter 6 Dracunculiasis

(8)

6.1 Life History and Host Range

(1)

6.2 Transmission to Humans

(1)

6.3 Diagnosis

(1)

6.4 Distribution, Prevalence, and Intensity

(1)

6.5 Morbidity

(1)

6.6 Prevention and Control

(2)

References

(2)

Chapter 7 Food-Borne Trematodiasis

(36)

7.1 Food Security and Food Safety

(1)

7.2 Life Histories and Host Ranges

(3)

7.3 Risk Factors Involved in Transmission and Establishment of Infection

(2)

7.4 Diagnosis

(3)

7.4.1 Parasitological Diagnosis

(1)

7.4.2 Immunodiagnosis

(1)

7.4.3 Clinical Diagnosis

(1)

7.4.3.1 Fascioliasis

(1)

7.4.3.2 Fasciolopsiasis

(1)

7.4.3.3 Clonorchiasis

(1)

7.4.3.4 Opisthorchiasis

(1)

7.4.3.5 Metagonimiasis (Representative of Intestinal Fluke Infections)

(1)

7.4.3.6 Paragonimiasis

(1)

7.5 Epidemiology

(8)

7.5.1 Fascioliasis

(1)

7.5.2 Clonorchiasis

100

(1)

7.5.3 Intestinal Trematodiasis

101

(3)

7.5.4 Opisthorchiasis

104

(2)

7.5.5 Paragonimiasis

106

(1)

7.6 Morbidity

107

(5)

7.6.1 Liver Flukes and Disease

108

(3)

7.6.1.1 Fascioliasis

108

(1)

7.6.1.2 Clonorchiasis

108

(1)

7.6.1.3 Opisthorchiasis

109

(2)

7.6.2 Intestinal Flukes and Disease

111

(1)

7.6.3 Lung Flukes and Disease

111

(1)

7.7 Anthelminthic Treatment

112

(1)

7.8 Prevention and Control of Food-Borne Trematodiasis

113

(8)

7.8.1 Prevention and Control in the Community

114

(4)

7.8.2 Prevention and Control in Commercial Aquaculture

118

(3)

References

121

(6)

Chapter 8 Lymphatic Filariasis

127

(22)

8.1 Life History and Host Range

127

(3)

8.2 Microfilaremia

130

(1)

8.3 Transmission

130

(1)

8.4 Diagnosis

131

(5)

8.4.1 Parasitological Diagnosis

132

(1)

8.4.2 PCR Technology

132

(1)

8.4.3 Immunodiagnosis

133

(1)

8.4.4 Clinical Diagnosis and Pathogenesis

133

(3)

8.5 Distribution

136

(1)

8.6 Filarial Population Biology and the Elimination of LF

137

(1)

8.7 Morbidity

138

(3)

8.8 Tropical Pulmonary Eosinophilia

141

(1)

8.9 Anthelminthic Treatment

142

(1)

8.9.1 Drug Combination for LF in Countries Where Onchocerciasis and Loiasis Are Not Co-Endemic

142

(1)

8.9.2 Drug Combination for LF in Countries Where Onchocerciasis and Loiasis Are Co-Endemic

143

(1)

8.10 Prevention and Control in Support of Mass Drug Administration

143

(2)

8.11 Social and Economic Costs of Lymphatic Filariasis

145

(1)

References

146

(3)

Chapter 9 Onchocerciasis

149

(20)

9.1 Life History and Host Range

150

(2)

9.1.1 Life History

150

(1)

9.1.2 Intermediate Hosts and Vectors

151

(1)

9.2 Transmission

152

(2)

9.2.1 Vector-Borne Transmission

152

(1)

9.2.2 Evidence for Transplacental Transmission

153

(1)

9.3 Microfilaremia

154

(1)

9.4 Diagnosis

154

(5)

9.4.1 Parasitological Diagnosis

154

(2)

9.4.2 Clinical Diagnosis

156

(2)

9.4.2.1 Skin Appearance

156

(1)

9.4.2.2 Nodules (Onchocercomata)

157

(1)

9.4.2.3 Ocular Signs and Symptoms

158

(1)

9.4.2.4 Lymphatic Signs and Symptoms

158

(1)

9.4.3 Immunological and Molecular Diagnosis

158

(1)

9.4.4 DEC Patch Test

159

(1)

9.5 Distribution and Epidemiology

159

(1)

9.5.1 Onchocerca volvulus in the Savannah and Forest Regions (Bioclimes) of Africa

159

(1)

9.5.2 Onchocerca volvulus in the Community

160

(1)

9.6 Morbidity

160

(1)

9.7 Prevention and Control

161

(3)

9.7.1 The Onchocerciasis Control Program (OCP) in West Africa

161

(2)

9.7.2 Mass Distribution and Use of Ivermectin in the Community

163

(1)

9.7.3 Exit Strategy

164

(1)

References

164

(5)

Chapter 10 Schistosomiasis

169

(34)

10.1 Life History and Host Range

169

(3)

10.2 Transmission and Establishment of Infection in Humans

172

(4)

10.2.1 Water Contact

172

(2)

10.2.2 Skin Penetration and Tissue Migration

174

(2)

10.3 Diagnosis

176

(3)

10.3.1 Parasitological Diagnosis

176

(1)

10.3.2 Diagnosis of Schistosomiasis Haematobium by Questionnaire

177

(1)

10.3.3 Immunodiagnosis

178

(1)

10.3.4 Clinical Diagnosis

179

(1)

10.4 Epidemiology

179

(4)

10.4.1 Prevalence

179

(2)

10.4.2 Intensity

181

(2)

10.5 Pathogenesis and Morbidity

183

(4)

10.5.1 Schistosome Eggs and Granulomas

184

(1)

10.5.2 Progressive Morbidity during Schistosomiasis

185

(1)

10.5.3 Female Genital Schistosomiasis (FGS)

186

(1)

10.5.4 Bladder Cancer

186

(1)

10.5.5 Ectopic Schistosomiasis

186

(1)

10.5.6 Extent of Morbidity and Mortality during Schistosomiasis

187

(1)

10.6 Immunity

187

(1)

10.7 Prevention and Control

188

(9)

10.7.1 Anthelminthic Treatment with Praziquantel

189

(7)

10.7.1.1 Impact of Praziquantel Treatment on Schistosomiasis

191

(1)

10.7.1.2 Praziquantel, Pregnancy, and Lactation

191

(4)

10.7.1.3 Therapeutic Efficacy of Praziquantel

195

(1)

10.7.1.4 Other Deworming Treatments for Schistosomiasis

195

(1)

10.7.2 Vaccination Prospects

196

(1)

10.7.3 Sustainable Progress

197

(1)

References

197

(6)

Chapter 11 Soil-Transmitted Helminthiasis

203

(44)

11.1 Life History and Host Range

203

(1)

11.2 Transmission and Establishment of Infection

203

(4)

11.2.1 Ascaris lumbricoides

204

(2)

11.2.2 Ancylostoma duodenale and Necator americanus

206

(1)

11.2.3 Trichuris trichiura

206

(1)

11.3 Diagnosis

207

(1)

11.4 Epidemiology

207

(11)

11.4.1 Prevalence

208

(4)

11.4.2 Intensity

212

(4)

11.4.3 Distribution of Numbers of Soil-Transmitted Helminth per Host

216

(1)

11.4.4 Predisposition to Infection with Soil-Transmitted Helminths

217

(1)

11.5 Risk Groups, Morbidity, and Pathology

218

(14)

11.5.1 Ascariasis

219

(2)

11.5.2 Hookworm Disease (Ancylostomiasis and Necatoriasis)

221

(8)

11.5.2.1 Hookworm Disease and Worker Productivity

222

(2)

11.5.2.2 Hookworm Disease, Pregnancy, and Lactation

224

(4)

11.5.2.3 Hookworm Disease, Cognitive Development, and Educational Achievement

228

(1)

11.5.3 Trichuriasis

229

(1)

11.5.4 Larval Migrations and Morbidity

230

(1)

11.5.5 Soil-Transmitted Helminths, HIV/AIDS, Malaria, and TB

231

(1)

11.6 Allergy and Immunity

232

(1)

11.7 Anthelminthic Treatment

233

(2)

11.8 Control Strategies for the Use of Anthelminthic Drugs

235

(2)

11.9 Treatment of School-Aged Children

237

(1)

11.10 Prevention and Control

238

(1)

References

238

(9)

Chapter 12 Strongyloidiasis

247

(14)

12.1 Species, Host Range, and Life History

247

(4)

12.1.1 Strongyloides stercoralis

248

(2)

12.1.2 Strongyloides fuelleborni

250

(1)

12.1.3 Strongyloides fuelleborni kellyi

250

(1)

12.2 Identification and Diagnosis

251

(1)

12.3 Distribution and Abundance

252

(2)

12.4 Pathology, Morbidity, and Mortality

254

(2)

12.4.1 Chronic Uncomplicated Strongyloidiasis

255

(1)

12.4.2 Severe Complicated Strongyloidiasis

255

(1)

12.5 Anthelminthic Treatment

256

(1)

12.6 Prevention and Control

257

(1)

References

257

(4)

Chapter 13 Trichinellosis (Trichinosis)

261

(12)

13.1 Transmission of Species of Trichinella to Humans

261

(2)

13.2 Development and Life History

263

(2)

13.3 Muscle Distribution of Trichinella Larvae

265

(1)

13.4 Diagnosis

265

(2)

13.4.1 Animal Hosts

265

(2)

13.4.2 Human Hosts

267

(1)

13.5 Epidemiology

267

(2)

13.6 Allergy and Immunity

269

(1)

13.7 Pathogenesis and Morbidity

269

(1)

13.8 Treatment

270

(1)

13.9 Prevention and Control

270

(1)

References

270

(3)

PART III Control Interventions

273

(60)

Chapter 14 Use of Anthelminthic Drugs in the Public Health Arena

275

(24)

14.1 Epidemiology

279

(1)

14.1.1 Theoretical Aspects

279

(1)

14.1.2 Practical Epidemiology in Relation to the Use of Anthelminthic Drugs

279

(1)

14.2 Safety and Therapeutic Efficacy and Effectiveness

280

(1)

14.3 Treatment Strategies

281

(2)

14.4 Reinfection

283

(1)

14.5 Drug Resistance

283

(6)

14.5.1 Theoretical Aspects

284

(1)

14.5.2 The Reality of Drug Resistance

284

(1)

14.5.3 Is There Evidence of Drug Resistance in Helminths Infecting Humans?

285

(1)

14.5.4 Detection of Drug Resistance

286

(2)

14.5.5 Measures to Delay and Avoid the Emergence of Drug Resistance

288

(1)

14.5.6 Porous Borders

289

(1)

14.6 Costs and Cost Effectiveness of Deworming

289

(5)

References

294

(5)

Chapter 15 Health Awareness and Helminthiasis

299

(14)

15.1 Education and the Risk of Helminth Infection

299

(1)

15.2 Assessment of Health Awareness

300

(3)

15.3 Impact of Health Awareness in the Control of Helminthiasis

303

(4)

15.4 Elements in Planning for Health Education

307

(1)

15.5 Health Education in the School System

308

(1)

15.6 Cost-Effectiveness of Health Education

309

(1)

References

310

(3)

Chapter 16 Water and Sanitation: Availability, Needs, and Provision

313

(12)

16.1 Night Soil

315

(1)

16.2 Urbanization

315

(2)

16.3 Water: Availability and Needs

317

(1)

16.4 Sanitation: Availability and Needs

317

(1)

16.5 Provision of Sanitation

318

(3)

16.6 Intervention Outcomes

321

(1)

16.7 Prospects for the Provision of Water Supplies and Sanitation

322

(1)

References

323

(2)

Chapter 17 Helminthiasis and the Millennium Development Goals

325

(8)

17.1 Millennium Development Goals

325

(1)

17.2 Helminthiasis and the G8 Agenda

326

(1)

17.3 Contribution of Deworming to the MDGs

327

(2)

17.4 Deworming — Top Down or Bottom Up?

329

(1)

17.5 Deworming through Participatory Rural Appraisal

329

(1)

17.6 Conclusion

330

(1)

References

331

(2)

Appendix 1: Glossary of Some Terms and Abbreviations Relating to Human Host-Helminth Interactions and Helminthiasis

333

(6)

Appendix 2: Journals for Helminthology, Helminthiasis, and Control Interventions

339

(2)

Appendix 3: Methods for the Detection of Helminth Eggs in Stool Samples

341

(6)

Appendix 4: A Model Framework for the Control of Morbidity Due to FBT Infections

347

(6)

Index

353

Please wait while the item is added to your bag...

FREE SHIPPING

Rent More, Save More! Use code: BBRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

Handbook of Helminthiasis for Public Health

Summary

Table of Contents

Supplemental Materials

FREE SHIPPING

Rent More, Save More! Use code: BBRENTAL

5% off 1 book, 7% off 2 books, 10% off 3+ books

Handbook of Helminthiasis for Public Health

Summary

Table of Contents

Supplemental Materials

Digital License